- Published on
Oura is reportedly eyeing a September IPO that could value it at more than $16B
- Authors
- Name
- DeepHorus
Oura, the Finland and San Francisco-based smart ring pioneer, is reportedly planning a U.S. initial public offering as soon as September that could value the company at over $16 billion, according to a Bloomberg report. This ambitious IPO target, which could see the company raise up to $3 billion, represents a significant financial milestone for the wearable technology firm. The timing of the offering would mark a rapid ascent for the company, which has navigated both explosive growth and increased competition in the health-tech space.
This move comes on the heels of strong financial performance and strategic evolution. Oura confidentially filed for an IPO in May, setting the stage for a public offering. The company has reported impressive revenue growth, stating it generated $500 million in 2024, reached approximately $1 billion in 2025, and projects nearly $2 billion in revenue for 2026. This financial trajectory provides a solid foundation for a high valuation, attracting significant investor interest ahead of the filing.
The proposed $16 billion valuation would mark a substantial leap from the $10.9 billion valuation Oura secured just last September during an $875 million Series E funding round. That round was supported by major institutional investors including Fidelity, ICONIQ, Whale Rock, and Atreides. The report notes that existing investors are expected to sell a major portion of their stock in the offering, providing liquidity for early backers.
Oura's success is rooted in its transition from a niche product for biohackers to a mainstream health and wellness device. The company's smart ring tracks sleep, recovery, heart rate, and body temperature, using advanced sensors and algorithms to provide users with detailed health insights. This evolution has allowed it to capture a broader consumer market, positioning it as a key player in the expanding wearables sector, which has seen increased activity from rivals like Samsung and Whoop.
The IPO would have a significant impact on the wearables industry and its investors. A successful offering would validate the high-growth potential of health-focused wearables beyond traditional fitness trackers. It would also provide substantial returns for venture capital firms and early investors, potentially fueling further investment into the health-tech ecosystem. For consumers, a public Oura might accelerate innovation and product development as the company faces quarterly earnings scrutiny.
Industry analysts are watching closely, noting the mix of impressive growth and potential risks. The positive sentiment is driven by Oura's strong revenue projections and its established brand in the recovery space. However, a proposed class-action lawsuit filed in San Francisco last week introduces a notable risk. The suit alleges Oura misled consumers about the clinical accuracy of its sleep staging features, claiming the technology cannot match hospital-grade polysomnography.
In response, an Oura spokesperson has firmly defended the company's technology, stating they will fight the claims in court. The company maintains its sleep staging has been validated in multiple independent studies against the gold standard of polysomnography. This legal challenge will be a key factor for potential investors to consider as the IPO process unfolds, potentially affecting timing or terms.
Looking ahead, the coming weeks will be critical. The company is expected to publicly file its S-1 registration statement, which will reveal comprehensive financial details, risk factors, and the definitive terms of the offering. Market conditions and investor appetite in the volatile tech sector will ultimately determine the IPO's success and final valuation. A strong debut would cement Oura's status as a top-tier public health-tech company.
This IPO occurs within the broader context of a maturing wearables market where differentiation through health metrics is paramount. It reflects a larger trend of health and wellness companies leveraging sophisticated biometric data to command premium valuations. Oura's public market journey will be a key test of whether specialized health wearables can sustain high growth and investor confidence as they scale into mainstream consumer electronics.
